Total Funding
24
Total FundingVenture - Series Unknown raised
Growth Score in past quarter
pts
Heat Score 24 in past quarter
-2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
142340
A precision microbiome engineering company developing alternatives to small-molecule antibiotics for use in agriculture and human health.
Acquired by 
Locus Biosciences
About the Company
EpiBiome is a venture-backed precision microbiome engineering company tackling the challenge of antibiotic resistance by developing alternatives to small-molecule antibiotics for use in healthcare, veterinary and agriculture industries.
Antibiotic-resistant bacteria surpass nuclear warfare, climate change, and terrorism as the biggest challenge
facing humanity today. The pipeline of new antibiotics has slowed to a trickle, while the emergence of multi-drug resistant bacteria is on an unprecedented trajectory. These bacteria threaten to reverse more than 100 years of medical progress by making all but the most necessary surgical procedures too risky due to the threat of post-operative infection.
Women Founded


